LENZ

LENZ Earnings Preview

LENZ Therapeutics, Inc. · Healthcare · $318M

14d until earnings

LENZ Earnings

Wednesday, May 06 2026
EPS Estimate
$-1.03
$-1.25 – $-0.55
Revenue Estimate
$2M
Current Price
$10.13

Data Signal Summary

1 bullish
3 bearish
Estimates down -11% Insider buying cluster Put/call 2.0 (bearish skew) Price downtrend

Key Context

Analyst Consensus
mixed
Insider Activity
selling
Price Trend
downtrend
From 52w High
-0.5%
Est. Revisions (30d)
-11.3% 2up/2dn
Analyst Target (mean)
$41 $20–$60 +306%
Options P/C Ratio
2.00
Est. Dispersion
68% 7 analysts
Insider Cluster
strong buy (officer)
Fund Convergence
strong Citadel, Two Sigma, D.E. Shaw

Recent Activity

insider trades 21 transactions
Buy · CHEVALLARD DANIEL R (Chief Financial Officer) ·7,500 shares ·$64,275
Buy · SCHIMMELPENNINK EVERT B. (Chief Executive Officer) ·28,089 shares ·$251,411
Buy · GEORGE JEFFREY P. (Director) ·5,592 shares ·$49,890
Sell · OLSSON SHAWN (Officer) ·10,000 shares ·$261,022
Exercise · OLSSON SHAWN (Officer) ·10,000 shares ·$20,800
16 more
Buy · CHEVALLARD DANIEL R ·2,198 shr ·$50,017
Buy · MCCOLLUM JAMES W ·10,500 shr ·$239,278
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·224,974 shr ·$10,352,017
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·135,304 shr ·$5,714,356
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·188,094 shr ·$7,423,920
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·260,713 shr ·$10,255,244
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·191,376 shr ·$6,506,784
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·200,000 shr ·$6,093,000
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·334,801 shr ·$10,107,818
Sell · VERSANT VENTURE CAPITAL VI, L.P. ·350,000 shr ·$10,150,000
Exercise · OLSSON SHAWN ·1,400 shr ·$2,912
Exercise · SCHIMMELPENNINK EVERT B. ·4,200 shr ·$4,368
Exercise · OLSSON SHAWN ·3,333 shr ·$6,933
Exercise · SCHIMMELPENNINK EVERT B. ·45,000 shr ·$46,800
Buy · CHEVALLARD DANIEL R ·3,188 shr ·$49,988
Buy · MCCOLLUM JAMES W ·31,332 shr ·$501,093
analyst ratings 1 rating
HC Wainwright & Co. Buy 15h ago